The Russian Sputnik V vaccine is 91.6 percent effective against symptomatic COVID-19 and 100 percent effective against severe and moderate disease, according to an interim analysis of phase 3 trial results.
The Latest on COVID-19
Updated on February 2 2021 at 2:00 p.m. PDT
The Russian Sputnik V vaccine is 91.6 percent effective against symptomatic COVID-19 and 100 percent effective against severe and moderate disease, according to an interim analysis of phase 3 trial results.
The U.K. coronavirus variant has mutated again, according to experts. The new mutation is being investigated to see whether it’s more resistant to available vaccines.
To speed up COVID-19 vaccinations, Moderna is researching adding more doses to their vials, according to Reuters. The pharmaceutical company says they may be able to go from 10 to 15 doses in a single vial.